DelveInsight’s Diabetic Macular Edema Market Insights Report offers a detailed analysis of disease, its causes, symptoms, diagnostics modalities, and treatment options. 

The Diabetic Macular Edema market report also offers comprehensive insights into DME market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing clinical trials, key collaboration in the space, and key pharmaceutical companies actively pushing the growth of Diabetic Macular Edema Market size forward. 

Diabetic-Macular-Edema-Market-Insights

Some of the key highlights from the Diabetic Macular Edema Market Insights: 

  • The total number of Diabetic Macular Edema cases in the EU-5 nations was 641,865 in 2020. During the forecasted period, 2021–2030, the Diabetic Macular Edema cases are expected to increase by 2030.
  • Germany had the highest number of Diabetic Macular Edema cases among the EU-5 countries.
  • Diabetic Macular Edema appears to impact more males than females, according to secondary research findings.
  • Major players such as Novartis, Genentech/Roche, Kodiak Sciences, Adverum  Biotechnologies, Graybug Vision, Ocuphire Pharma, Oxurion, Allergan (AbbVie)/Molecular Partners, Unity Biotechnology, and others are involved in developing therapies for the treatment and management of Diabetic Macular Edema. These therapies are currently under different stages of development. 
  • Key pipeline therapies in the Diabetic Macular Edema market include Beovu (brolucizumab), Faricimab, KSI-301, ADVM-022, GB-102, APX3330, THR-149, Luminate (ALG-1001, Risuteganib), UBX1325, among others.


Learn more by requesting for sample @
Diabetic Macular Edema Market Landscape 

Diabetic Macular Edema: Overview 

Diabetic Retinopathy, a well-known consequence of diabetes, causes Diabetic Macular Edema. In both industrialized and developing nations, Diabetic Retinopathy is the most common diabetic eye condition and the major cause of permanent blindness in persons in their working years.


For more insights into Disease, causes, and treatment, reach out to
Diabetic Macular Edema Treatment Landscape 

Diabetic Macular Edema Epidemiology Segmentation 

The Diabetic Macular Edema Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:

  • Diabetic Macular Edema Prevalence 
  • Age-Specific Diabetic Macular Edema Prevalence 
  • Gender-Specific Diabetic Macular Edema Prevalence 
  • Diagnosed and Treatable Cases of Diabetic Macular Edema


Visit for more @
Diabetic Macular Edema Epidemiological Insights 

Diabetic Macular Edema Market 

The Diabetic Macular Edema market size is anticipated to increase during the study period, 2018–2030. The growth of the Diabetic Macular Edema market is expected to be mainly driven by increasing changes in lifestyle, addressing barriers to screening, increasing patient pool of diabetes, personalization of treatment and new pathways and novel approaches.

Diabetic Macular Edema Pipeline Therapies and Key Companies 

  • Beovu (brolucizumab): Novartis
  • Faricimab: Genentech/Roche
  • KSI-301: Kodiak Sciences
  • ADVM-022: Adverum  Biotechnologies
  • GB-102: Graybug Vision
  • APX3330: Ocuphire Pharma
  • THR-149: Oxurion
  • Luminate (ALG-1001, Risuteganib): Allergan (AbbVie)/Molecular Partners
  • UBX1325: Unity Biotechnology


For more information, visit
Diabetic Macular Edema Market Analysis, Patient Pool and Emerging Therapies 

Diabetic Macular Edema Market Drivers 

  • Rising prevalent population
  • Technological advancements
  • Emerging therapies 
  • Extensive R&D


Scope of the Report

  • 11 Years Forecast
  • 7MM Coverage 
  • Descriptive overview of Diabetic Macular Edema, covering causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
  • Comprehensive insight into Diabetic Macular Edema epidemiology and treatment in the 7MM
  • Current and emerging therapies for Diabetic Macular Edema 
  • Diabetic Macular Edema market drivers and barriers 


Key Questions Answered in the Report

  • What was the Diabetic Macular Edema market share (%) distribution in 2017 and how it would look like in 2030?
  • What will be the total Diabetic Macular Edema market size, as well as market size by therapies, in the 7MM throughout the forecast period (2017-2030)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Diabetic Macular Edema market size during the forecast period (2017-2030)?
  • At what CAGR, the Diabetic Macular Edema market is expected to grow in 7MM during the forecast period (2017-2030)?


Get in touch with our Business executive @
Diabetic Macular Edema Market Landscape Analysis 


Table of Contents 

1

Key Insights

2

Report Introduction

3

Competitive Intelligence Analysis for Diabetic Macular Edema

4

Diabetic Macular Edema Market Overview at a Glance

5

Executive Summary of Diabetic Macular Edema

6

Diabetic Macular Edema Epidemiology and Market Methodology

7

Diabetic Macular Edema Epidemiology and Patient Population

8

Diabetic Macular Edema Patient Journey

9

Treatment Algorithm, Current Treatment, and Medical Practices

10

Key Endpoints in Diabetic Macular Edema Clinical Trials

11

Diabetic Macular Edema Marketed Therapies 

12

Diabetic Macular Edema Emerging Therapies

13

Diabetic Macular Edema: 7 Major Market Analysis

14

Attribute analysis

15

Access and Reimbursement Overview of Diabetic Macular Edema

16

KOL Reviews

17

Case Reports

18

Diabetic Macular Edema Market Drivers

19

Diabetic Macular Edema Market Barriers

20

SWOT Analysis

21

Disclaimer

22

DelveInsight Capabilities

23

About DelveInsight


Learn more about the report offerings @
Diabetic Macular Edema Market Outlook

Related Reports:

Diabetic Macular Edema Epidemiology

DelveInsight’s ‘Diabetic Macular Edema (DME)- Epidemiology Forecast to 2030’ report.

Diabetic Macular Edema Pipeline

DelveInsight’s “Diabetic Macular Edema (DME) Pipeline Insights, 2021” report.

Latest Reports:

Intrahepatic Cholangiocarcinoma (ICCA) Market

DelveInsight’s ‘Intrahepatic Cholangiocarcinoma (ICCA) – Market Insights, Epidemiology, and Market Forecast–2030’ report.

COVID 19 Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape, 2020

DelveInsight’s ‘COVID 19 (Novel Coronavirus 19) Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape, 2020’ report.

Cervical Dysplasia Market

DelveInsight’s “Cervical Dysplasia – Market Insights, Epidemiology, and Market Forecast-2030” report.

Agoraphobia Market

DelveInsight’s “Agoraphobia – Market Insights, Epidemiology, and Market Forecast-2030” report.

Hydrocephalus Market

DelveInsight’s “Hydrocephalus – Market Insights, Epidemiology, and Market Forecast-2030” report.

Sarcopenia Market

DelveInsight’s ‘Sarcopenia–Market Insights, Epidemiology, and Market Forecast-2030’ report.

Diabetic Kidney Disease Market

DelveInsight’s “Diabetic Kidney Disease (DKD) – Market Insights, Epidemiology, and Market Forecast-2030” report.

Acromegaly Market

DelveInsight’s ‘Acromegaly-Market Insights, Epidemiology, and Market Forecast–2030’ report.

Acute Respiratory Distress Syndrome (ARDS) Market

DelveInsight’s ‘Acute Respiratory Distress Syndrome (ARDS) – Market Insights, Epidemiology and Market Forecast – 2030’ report.

Acute Kidney Injury (AKI) Market

DelveInsight’s ‘Acute Kidney Injury (AKI) – Market Insights, Epidemiology and Market Forecast– 2030’ report.

Renal Anemia Market

DelveInsight’s “Renal Anemia – Market Insights, Epidemiology, and Market Forecast-2030” report.

Get in touch with our Business executive for Competitive Intelligence Services

Healthcare Blogs:

Diabetic Macular Edema Therapy Market to Witness Significant Impact in the Foreseeable Future

Top 7 Pharma Industry Leaders in 2020 By the Numbers

About DelveInsight 

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance.  

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Tags: dmemarket, diabeticmacularedemapipelinetherapies, diabeticmacularedematherapies, diabeticmacularedemakeycompanies, diabeticmacularedemaepidemiology, dmemarketshare, dmemarketsize, diabeticmacularedemamarketresearchreports, diabeticmacularedemamarket, diabeticmacularedemamarketshare, diabeticmacularedemamarketsize, diabeticmacularedemamarketsizeandshare

See Campaign: https://www.delveinsight.com/
Contact Information:
Kritika Rehani info@delveinsight.com +1(919)321-6187

Tags:
Menafn, IPS, Reportedtimes, PR-Wirein, iCN Internal Distribution, Extended Distribution, Research Newswire, English